Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(3.26)
# 1,048
Out of 4,732 analysts
185
Total ratings
28.42%
Success rate
8.07%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUMA Humacyte | Reiterates: Buy | $12 → $15 | $4.41 | +240.14% | 5 | Dec 20, 2024 | |
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.21 | +643.80% | 7 | Dec 18, 2024 | |
| CADL Candel Therapeutics | Reiterates: Buy | $11 → $19 | $6.67 | +185.07% | 5 | Dec 18, 2024 | |
| NVAX Novavax | Reiterates: Buy | $19 | $8.40 | +126.19% | 22 | Dec 10, 2024 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $5 | $1.15 | +334.78% | 10 | Dec 9, 2024 | |
| WINT Windtree Therapeutics | Reiterates: Neutral | $7 | $0.22 | +3,094.89% | 2 | Dec 4, 2024 | |
| SAVA Cassava Sciences | Downgrades: Neutral | $116 | $2.75 | +4,118.18% | 22 | Nov 26, 2024 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $4.01 | +373.82% | 5 | Nov 25, 2024 | |
| ELDN Eledon Pharmaceuticals | Reiterates: Buy | $16 | $4.02 | +298.01% | 9 | Nov 20, 2024 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $2.22 | +260.36% | 14 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.85 | +135.88% | 8 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.66 | +954.53% | 6 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.50 | +300.00% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $3.30 | +2,930.30% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.55 | +1,061.29% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $1.70 | +1,135.22% | 10 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $2.77 | +1,199.64% | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.35 | +2,724.86% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $1.88 | +2,293.62% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.72 | +1,066.18% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $6.01 | +261,963.23% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.77 | +3,157.75% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $14.05 | +1,608.19% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.15 | +6,856.52% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $1.21 | +8,164.46% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $6.37 | +125,496.58% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $2.89 | +142.21% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.72 | +1,001.20% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $3.09 | +1,194.50% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $0.40 | +4,370.94% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.24 | +303.23% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $4.40 | +32,627.27% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $45.74 | -47.53% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $2.90 | +117,831.03% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $5.64 | +336,976.66% | 1 | Oct 6, 2017 |
Humacyte
Dec 20, 2024
Reiterates: Buy
Price Target: $12 → $15
Current: $4.41
Upside: +240.14%
Cardiol Therapeutics
Dec 18, 2024
Reiterates: Buy
Price Target: $9
Current: $1.21
Upside: +643.80%
Candel Therapeutics
Dec 18, 2024
Reiterates: Buy
Price Target: $11 → $19
Current: $6.67
Upside: +185.07%
Novavax
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $8.40
Upside: +126.19%
Artelo Biosciences
Dec 9, 2024
Reiterates: Buy
Price Target: $5
Current: $1.15
Upside: +334.78%
Windtree Therapeutics
Dec 4, 2024
Reiterates: Neutral
Price Target: $7
Current: $0.22
Upside: +3,094.89%
Cassava Sciences
Nov 26, 2024
Downgrades: Neutral
Price Target: $116
Current: $2.75
Upside: +4,118.18%
NRx Pharmaceuticals
Nov 25, 2024
Reiterates: Buy
Price Target: $19
Current: $4.01
Upside: +373.82%
Eledon Pharmaceuticals
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $4.02
Upside: +298.01%
GeoVax Labs
Nov 20, 2024
Reiterates: Buy
Price Target: $8
Current: $2.22
Upside: +260.36%
Nov 15, 2024
Reiterates: Buy
Price Target: $2
Current: $0.85
Upside: +135.88%
Nov 15, 2024
Reiterates: Buy
Price Target: $7
Current: $0.66
Upside: +954.53%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.50
Upside: +300.00%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $3.30
Upside: +2,930.30%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.55
Upside: +1,061.29%
Aug 20, 2024
Reiterates: Buy
Price Target: $21
Current: $1.70
Upside: +1,135.22%
May 14, 2024
Reiterates: Buy
Price Target: $36
Current: $2.77
Upside: +1,199.64%
Jan 30, 2024
Initiates: Buy
Price Target: $10
Current: $0.35
Upside: +2,724.86%
Dec 14, 2023
Initiates: Buy
Price Target: $45
Current: $1.88
Upside: +2,293.62%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $1.72
Upside: +1,066.18%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $6.01
Upside: +261,963.23%
Mar 8, 2023
Reiterates: Buy
Price Target: $25
Current: $0.77
Upside: +3,157.75%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $14.05
Upside: +1,608.19%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.15
Upside: +6,856.52%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $1.21
Upside: +8,164.46%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $6.37
Upside: +125,496.58%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $2.89
Upside: +142.21%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.72
Upside: +1,001.20%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $3.09
Upside: +1,194.50%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $0.40
Upside: +4,370.94%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $1.24
Upside: +303.23%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $4.40
Upside: +32,627.27%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $45.74
Upside: -47.53%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $2.90
Upside: +117,831.03%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $5.64
Upside: +336,976.66%